Women Underwent TRAM Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic Exercises
Post-mastectomy Women Underwent Transverse Rectus Abdominis Musculocutaneous Flap (TRAM) Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic Exercises
1 other identifier
interventional
82
0 countries
N/A
Brief Summary
The unilateral transverse rectus abdominis musculocutaneous (TRAM) flap is a major operation widely used for breast reconstruction. It is hypothesized that this surgery has the potential risk of weakening the abdominal wall because it disrupts the integrity of the rectus abdominis muscle (RA), therefore, alters the insertion of the oblique muscles and the biomechanical relationship between the RA muscle and adjacent structures. The purposes of this study were to examine the effects of the TRAM flap surgery on muscle size of abdominal muscles, strength and endurance of trunk muscles, strength and endurance of core stability, as well as the effects of therapeutic exercises on it in post-mastectomy women underwent TRAM surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2009
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 24, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 8, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 8, 2014
CompletedFirst Submitted
Initial submission to the registry
May 11, 2021
CompletedFirst Posted
Study publicly available on registry
May 14, 2021
CompletedMay 14, 2021
February 1, 2021
5.5 years
May 11, 2021
May 11, 2021
Conditions
Outcome Measures
Primary Outcomes (6)
Changes in thickness of abdominal wall muscles at 12-week
Using the Ultrasound imaging to measure the thickness of all abdominal wall muscles at rest and in an isometric contraction.
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in the cross-sectional area of the rectus abdominis muscle (RA) muscle at 12-week
Using the Ultrasound imaging to measure the cross-sectional area of the rectus abdominis muscle at rest and in an isometric contraction.
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in strength of the trunk muscles at 12-week
Using the dynamometer and clinical tests (prone extension, curl-up and rotational curl-up) to measure the trunk strength
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in endurance of the trunk muscles at 12-week
Using the clinical tests (abdominal muscle test for strength, unsupported double bend leg lifting for static endurance) to measure the endurance of trunk muscles
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in balanced functions at 12-week
Using the seconds in the following static position to measure the balance: one-leg standing with the other lift-leg 1 inch of ground clearance; single leg standing with the other lift-leg hip flexion 90 degrees and the tibia vertical to the floor.
The assessments will be conducted 1 and 12 weeks following the intervention
Changes in muscle activity of selected trunk and limb muscles at 12-week
Using A six-camera Qualisys motion system to measure the muscle activity of selected trunk and limb muscles.
The assessments will be conducted 1 and 12 weeks following the intervention
Study Arms (3)
TRAM abdominal muscle training group
EXPERIMENTALPatients were recruited at least 6 months after the muscle-sparing (MS) pedicled Transverse rectus abdominis musculocutaneous (TRAM) flap procedure and at least 1 month after the conclusion of the last chemotherapy course, if any. All subjects will receive 1-hr training sessions consisting of core stability exercises for 12 weeks for the TRAM group.
TRAM control group
NO INTERVENTIONPatients were recruited at least 6 months after the muscle-sparing (MS) pedicled Transverse rectus abdominis musculocutaneous (TRAM) flap procedure and at least 1 month after the conclusion of the last chemotherapy course, if any. The control group was not received any exercise program.
Healthy women group
NO INTERVENTIONA control group comprising female volunteers who were apparently healthy and had comparable socioeconomic backgrounds and physical conditions was recruited by convenience sampling from communities.
Interventions
Participants will receive 12-week, 60 minutes, 36-session abdominal muscle training in the TRAM women. Aimed to evaluate the effects on abdominal muscle functions after 12 weeks abdominal muscle training in the TRAM women. Outcome measures were the clinical tests for trunk muscle strength, endurance and one-leg standing was also used to exam the abdominal muscle function.
Eligibility Criteria
You may qualify if:
- Healthy adults
- Their age should be ranged between 30 - 60 years
- TRAM flap surgery patients
- at least 6 months after the MS pedicled TRAM flap surgery
You may not qualify if:
- Healthy adults
- a history of injury resulting in an inability to perform activities of daily living
- scoliosis or spinal surgery
- neurological, neuromuscular, rheumatological or systemic diseases
- TRAM flap surgery patients
- tumor distant metastasis
- a history of injury resulting in an inability to perform activities of daily living
- scoliosis or spinal surgery
- neurological, neuromuscular, rheumatological or systemic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Li-Jiun Liaw
Kaohsiung Medical University Department of Physical Therapy Associate Professor
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2021
First Posted
May 14, 2021
Study Start
February 24, 2009
Primary Completion
September 8, 2014
Study Completion
September 8, 2014
Last Updated
May 14, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share
Currently in the submission stage ,and then share with other researchers after publication